In support of this hypothesis, analysis of the tumor-specific CD8+ T cell response in CD1d1−/− mice using TBL-OVA cells and Kb/SIINFEKL tetramers indicated that the anti-tumor CD8+ T cell response was similar to that seen in WT mice (Figure 6C). This evidence concerns the gene CD8A and neoplasm.